• Higher prevalence of TNF-α -238 promotor polymorphism in NAFLD/NASH patients, in Italian,176 Mexican177 and Chinese107,178 cohorts. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.